Funding news
Signadori Bio logo

Signadori Bio Secures $13.1M Seed Funding

Recently funded · $13.1M SeedHospitals and Health CareFRView source

Get the full Signadori Bio company profile

Access contacts, investors, buying signals & more

Open in Dashboard

A new approach to tackling solid tumours has attracted significant early investment for Signadori Bio. The Paris-based preclinical biopharmaceutical company announced it has closed a $13.1M Seed funding round, with capital coming from Taiho Oncology and Sofinnova Partners.

Signadori Bio, founded by Dr Jean-Luc Perfettini and Professor Nathalie Chaput, is developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform. Based on research from Gustave Roussy, its technology aims to overcome the challenges of the tumour microenvironment by harnessing gene-modified monocytes.

Great milestone for Signadori Bio with the closing of its €11.1M seed round. Congrats to the team, the scientific founders Jean-Luc PERFETTINI Nathalie CHAPUT and to Selwyn Ho for getting this done, an important step forward for the company. Very happy as well to welcome Taiho Oncology as a new investor. Looking forward to the next chapter! Sofinnova Partners Maxime Bennett

Other France companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
OpenTrade logo

OpenTrade

United Kingdom

$17.0M
2
InstaSwitch logo

InstaSwitch

United States

$4.7M
3
Eaship TMS logo

Eaship TMS

Spain

$1.2M
4
Moonlight AI logo

Moonlight AI

Switzerland

$3.3M
5
Bannersnack logo

Bannersnack

Romania

$1.2M